View in EDS

Economic Evaluation of Axicabtagene Ciloleucel as a Second-Line Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in South Korea: A Cost-Utility Analysis Based on the ZUMA-7 Trial.

Saved in:
Bibliographic Details
Title: Economic Evaluation of Axicabtagene Ciloleucel as a Second-Line Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in South Korea: A Cost-Utility Analysis Based on the ZUMA-7 Trial.
Authors: Lee J; Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul, South Korea.; Institute of Regulatory Innovation through Science (IRIS), Kyung Hee University, Seoul, South Korea., Kim M; Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul, South Korea.; Institute of Regulatory Innovation through Science (IRIS), Kyung Hee University, Seoul, South Korea., Jang M; Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul, South Korea.; Institute of Regulatory Innovation through Science (IRIS), Kyung Hee University, Seoul, South Korea., Jo S; Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul, South Korea.; Institute of Regulatory Innovation through Science (IRIS), Kyung Hee University, Seoul, South Korea., Lee S; Gilead Science Korea Ltd., Seoul, South Korea., Suh HS; Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul, South Korea. haesun.suh@khu.ac.kr.; Institute of Regulatory Innovation through Science (IRIS), Kyung Hee University, Seoul, South Korea. haesun.suh@khu.ac.kr.; College of Pharmacy, Kyung Hee University, 26, Kyunghee-daero, Dongdaemun-gu, Seoul, 02447, Republic of Korea. haesun.suh@khu.ac.kr.
Source: Clinical drug investigation [Clin Drug Investig] 2026 May 08. Date of Electronic Publication: 2026 May 08.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-1918
DOI:10.1007/s40261-026-01557-9